-
The achievement of a new model of health management, and a new model of optimization of health resources for the diagnosis and treatment of degenerative diseases of the Central Nervous System.
-
The diffusion of the EuroEspes model to other geographical areas.
-
Execution of studies of preventive medicine and of risk detection, identifying the health, welfare and nutritional needs of the Spanish population.
-
Prevention plans for high-risk groups and development of the Plan for the Genetic Prevention of Dementia, proposed to the international scientific community by EuroEspes in Geneva in 1998.
-
Implementation and development of the Cerebral Risk Prevention Plan, and the School Failure Prevention Program.
1. To investigate the possible causes of Central Nervous System disorders
2. To design and implement Preventive Programs for diseases of the Central Nervous System.
3. To establish pioneering therapeutic strategies.
In this line of action, EuroEspes is the first group worldwide to design a clinical protocol for the diagnosis of diseases of the Central Nervous System, linked with a multifactorial therapeutic strategy for senile dementia and a pharmacogenomic intervention program for Alzheimer’s disease.
See Most Common Pathologies
Origin of our Patients
|
The EuroEspes Pharmacogenetic Card is of the greatest usefulness in matters concerning cardiac diseases, arterial hypertension, diabetes, hypercholesterolemia, cancer, the use of anticoagulants such as Sintrom, and different diseases of the Central Nervous System such as epilepsy, depression, schizophrenia, anxiety, Parkinson’s disease or senile dementia.
Find out more »
|
 |
|
